Back to Search
Start Over
Long-Term Observation of Improvement in Liver Fibrosis Index by A Glucagon-Like Peptide-1 Receptor Agonist in A Patient with Type 2 Diabetes: A Case Report
- Source :
- Archives of Clinical and Medical Case Reports.
- Publication Year :
- 2020
- Publisher :
- Fortune Journals, 2020.
-
Abstract
- We describe a 51-year-old man with type 2 diabetes and hepatic dysfunction with suspected nonalcoholic fatty liver disease (NAFLD)/nonalcoholic steatohepatitis (NASH). No liver biopsy was performed. His blood test showed a decrease in platelet count (PLT) of 6.3 × 104/μL. Serum levels of aspartate aminotransferase (AST) and alanine aminotransferase (ALT) were increased, and the AST/ALT ratio (AAR) exceeded 1. FIB4 index, an index of liver fibrosis, was remarkably high at 7.65. On abdominal computed tomography (CT), hepatic parenchyma was visualized as a low absorption area (CT value: 36 HU, L/S ratio
- Subjects :
- medicine.medical_specialty
medicine.diagnostic_test
business.industry
Liraglutide
Type 2 Diabetes Mellitus
General Medicine
Type 2 diabetes
medicine.disease
digestive system
Gastroenterology
digestive system diseases
Liver biopsy
Internal medicine
Nonalcoholic fatty liver disease
medicine
Blood test
business
Exenatide
Glucagon-like peptide 1 receptor
medicine.drug
Subjects
Details
- ISSN :
- 25759655
- Database :
- OpenAIRE
- Journal :
- Archives of Clinical and Medical Case Reports
- Accession number :
- edsair.doi...........d1215f850c6a1d1a2737ced45cb0403f